Trends in antimicrobial susceptibility among isolates of Campylobacter species in Ireland and the emergence of resistance to ciprofloxacin

Measurements were made of the susceptibility to six commonly prescribed antibiotics, including erythromycin, tetracycline and ciprofloxacin, of 130 isolates of Campylobacter jejuni and 15 isolates of Campylobacter coli cultured from human and poultry sources during 2000. The results were compared with the results from a collection of strains isolated between 1996 and 1998. The levels of resistance to erythromycin remained low, 2 per cent and 4.4 per cent for the human and poultry isolates, respectively. Resistance to tetracycline had increased to 31 per cent and 24.4 per cent from 13.9 per cent and 18.8 per cent for the human and poultry isolates, respectively. However, the resistance to ciprofloxacin of the strains isolated during 2000 had increased to 30 per cent, whereas between 1996 and 1998 there had been no resistance to this agent among human isolates, and only 3-1 per cent resistance among poultry isolates. The molecular basis for this resistance has been shown to be the result of a single amino acid substitution, Thr-86-lle, in the gyrA subunit of DNA gyrase in C jejuni. A subset of 59 isolates was tested by molecular methods and all of the 25 phenotypically resistant isolates possessed this substitution. None of the human isolates had been treated with ciprofloxacin before their laboratory isolation.

[1]  R. Davidson.  Control and eradication of animal diseases in New Zealand , 2002, New Zealand veterinary journal.

[2]  B. Duim,et al.  Evidence for a Genetically Stable Strain ofCampylobacter jejuni , 2001, Applied and Environmental Microbiology.

[3]  S. Fanning,et al.  Antimicrobial resistance profiling and DNA Amplification Fingerprinting (DAF) of thermophilic Campylobacter spp. in human, poultry and porcine samples from the Cork region of Ireland , 2000, Journal of applied microbiology.

[4]  B. Swaminathan,et al.  Characterization of gyrA mutations associated with fluoroquinolone resistance in Campylobacter coli by DNA sequence analysis and MAMA PCR. , 2000, FEMS microbiology letters.

[5]  J. Frost,et al.  Drug resistance in Campylobacter jejuni, C coli, and C lari isolated from humans in north west England and Wales, 1997. , 1999, Journal of clinical pathology.

[6]  C. Hoge,et al.  Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  Thomas L. Madden,et al.  Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. , 1997, Nucleic acids research.

[8]  C. Gaudreau,et al.  Comparison of disc diffusion and agar dilution methods for antibiotic susceptibility testing of Campylobacter jejuni subsp. jejuni and Campylobacter coli. , 1997, The Journal of antimicrobial chemotherapy.

[9]  R. Pebody,et al.  Outbreaks of campylobacter infection: rare events for a common pathogen. , 1997, Communicable disease report. CDR review.

[10]  B. Kaijser,et al.  DNA fingerprinting and serotyping of Campylobacter jejuni isolates from epidemic outbreaks , 1996, Journal of clinical microbiology.

[11]  P. Gaunt,et al.  Ciprofloxacin resistant Campylobacter spp. in humans: an epidemiological and laboratory study. , 1996, The Journal of antimicrobial chemotherapy.

[12]  A. Serra,et al.  Susceptibilities to 10 antimicrobial agents of 1,220 Campylobacter strains isolated from 1987 to 1993 from feces of pediatric patients , 1994, Antimicrobial Agents and Chemotherapy.

[13]  K. Sutherland,et al.  Inhibition of DNAse activity in PFGE analysis of DNA from Campylobacter jejuni , 1994, Letters in applied microbiology.

[14]  H. Goossens,et al.  Discrimination among thermophilic Campylobacter species by polymerase chain reaction amplification of 23S rRNA gene fragments , 1994, Journal of clinical microbiology.

[15]  W. M. Huang,et al.  Cloning and nucleotide sequence of the Campylobacter jejuni gyrA gene and characterization of quinolone resistance mutations , 1993, Antimicrobial Agents and Chemotherapy.

[16]  F. Aarestrup,et al.  Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates. , 2001, Emerging infectious diseases.

[17]  E. J. Threlfall,et al.  Antimicrobial drug resistance in non-typhoidal salmonellas from humans in England and Wales in 1999: decrease in multiple resistance in Salmonella enterica serotypes Typhimurium, Virchow, and Hadar. , 2000, Microbial drug resistance.